CNO FINANCIAL GROUP INC
Q2 2026 Form 13-F
Filing Structure
Reports holdings for
- 40 86 Advisors Inc · File #028-17556 · since Q4 2016 · declared by one filing
- 40 (not a 13F filer in our records) · Q4 2017 – Q4 2017 · declared by one filing
- 40/86 Advisors, Inc. (not a 13F filer in our records) · Q4 2014 – Q3 2016 · declared by one filing
Key People
Directors & officers from Form 4 filingsDescription and Activity
CNO Financial Group, Inc. is an insurance holding company that develops, markets, and administers a variety of insurance and financial services products. The company primarily serves middle-income pre-retirees and retirees in the United States through a network of exclusive agents, independent producers, and direct marketing channels.
CNO operates through three main insurance product lines: annuities, health insurance, and life insurance. The company's annuity offerings include fixed indexed annuities that provide a guaranteed contract value and a tax-deferred method of accumulating savings for retirement. Health insurance products cover supplemental health, Medicare supplement, and long-term care, providing benefits for accidents, illnesses, hospital stays, and services not covered by Medicare. Life insurance offerings include traditional life insurance, whole life insurance, term life insurance, and universal life insurance, providing both death benefits and cash value components that can be used for savings or loans.
The company sells its products through two primary divisions: the Consumer Division and the Worksite Division. The Consumer Division focuses on individual consumers and distributes products through exclusive agents and independent producers. The Worksite Division targets employers and provides products through group sales channels. Continue reading...
CNO's major sources of income stem from the investment income earned on the underlying assets and the cost of index options purchased to provide returns based on external indices. The company has a significant presence in both the annuity and health insurance markets, collecting $1.583 billion in annuity premiums and $1.577 billion in health insurance premiums in 2023.
The company operates several subsidiaries, including Bankers Life and Casualty Company, Colonial Penn Life Insurance Company, and Washington National Insurance Company. These subsidiaries are licensed to operate in multiple states across the United States and the District of Columbia, as well as in Bermuda. They are subject to regulation by state insurance departments, the National Association of Insurance Commissioners (NAIC), and other federal authorities.
CNO's investment portfolio, managed by its subsidiary 40|86 Advisors, includes a mix of fixed-income securities, equities, and other investment products. This portfolio is subject to regulatory oversight to ensure compliance with investment regulations and to manage risks effectively.
As an employer, CNO Financial Group employs approximately 3,500 full-time associates and places a high priority on employee development, engagement, and well-being.
Overall, CNO Financial Group, Inc. is a comprehensive insurance provider, primarily focusing on middle-income consumers nearing or in retirement, with a strong regulatory compliance framework and a diverse portfolio of insurance and financial products.
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2026 13F record
Q2 2026 13F filing summary
| Period of report | June 30, 2026 |
|---|---|
| Filed | August 12, 2026 |
| Form | 13F-HR |
| Reported value | $174.7M |
| Positions | 8 |
| Change in reported value | +0.1% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2026 13F
Filed Aug 12, 2026
|
8 | $174.7M |
|
Q1 2026 13F
Filed May 13, 2026
|
8 | $174.4M |
|
Q4 2025 13F
Filed Feb 12, 2026
|
10 | $176.5M |
|
Q3 2025 13F
Filed Nov 13, 2025
|
8 | $150.6M |
|
Q2 2025 13F
Filed Aug 8, 2025
|
10 | $161.8M |
|
Q1 2025 13F
Filed May 14, 2025
|
9 | $119.6M |
|
Q3 2023 13F
Filed Nov 8, 2023
|
4 | $22.8M |
|
Q2 2023 13F
Filed Aug 3, 2023
|
4 | $28.5M |
|
Q1 2023 13F
Filed May 9, 2023
|
5 | $36.0M |
|
Q4 2022 13F
Filed Feb 10, 2023
|
5 | $64.5M |
|
Q3 2022 13F
Filed Nov 3, 2022
|
5 | $65.9M |
|
Q2 2022 13F
Filed Aug 4, 2022
|
5 | $66.3M |
|
Q1 2022 13F
Filed May 2, 2022
|
6 | $89.5M |
|
Q4 2021 13F
Filed Feb 9, 2022
|
7 | $108.0M |
|
Q3 2021 13F
Filed Nov 4, 2021
|
7 | $108.7M |
23 earlier quarters on file — choose one from the quarter menu above.
Top 8 holdings · Q2 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | BKLN INVESCO EXCH TRADED FD TR II | $35.5M | 20.34% |
| 2 | SRLN SSGA ACTIVE ETF TR | $34.7M | 19.88% |
| 3 | SPHY SPDR SERIES TRUST | $30.0M | 17.16% |
| 4 | JNK SPDR SERIES TRUST | $25.0M | 14.3% |
| 5 | PSK SPDR SERIES TRUST | $21.4M | 12.24% |
| 6 | USHY ISHARES TR | $11.8M | 6.78% |
| 7 | FTSL FIRST TR EXCHANGE-TRADED FD | $11.3M | 6.46% |
| 8 | HYG ISHARES TR | $5.0M | 2.84% |
Values as reported on the Q2 2026 Form 13F. Every position is in the holdings table below.